cost-effective. The aim of this study was to evaluate the cost-effectiveness of performing repeated interventions vs starting a new AVF.
Author Disclosures: B. S. Brooke: Nothing to disclose; R. E. Nelson: Nothing to disclose; C. L. Griffin: Nothing to disclose; L. S. Kraiss: Nothing to disclose. Objective: Peripheral artery disease is a growing health care burden, with rising costs related to use of lower extremity revascularization (LER). We sought to examine recent trends in procedure volumes by level of disease, provider specialty, and encounter setting.
Lower Extremity Revascularization in the
Methods: The Medicare claims database was queried for 2012 and 2016 LER Current Procedural Terminology codes, and data were extracted for allowed charges, allowed claims, billing provider, and procedure place of service. We examined trends in procedure by level of arterial disease treated. The breakdown of endovascular procedures in 2012 was 36% angioplasty, 43% stenting, and 21% atherectomy. Of these, 9%, 11%, and 26%, respectively, were performed in an office-based setting. Comparatively in 2016, endovascular interventions were composed of 35% angioplasty, 36% stenting, and 29% atherectomy, of which 16%, 23%, and 51%, respectively, were performed in an office-based setting (P < .001). There was no significant change in iliac interventions during the time period; however, differences were pronounced at the infrainguinal level. Total femoropopliteal interventions were 101,071 (47%) in 2012 and 118,540 (47%) in 2016, with atherectomy increasing from 25,038 (25%) in 2012 to 37,453 (32%) in 2016 (Fig) . Total tibial endovascular interventions increased strikingly from 56,378 (23%) in 2012 to 79,333 (32%) in 2016, a relative volume increase of 41%. This was driven largely by increased use of tibial atherectomy, 19,008 (34%) in 2012 vs 34,438 (43%) in 2016 (P < .001). Notably, office-based procedures accounted for the bulk of the increase in atherectomy in 2016 (Fig) . In keeping with the trend, atherectomy performed on an "additional tibial vessel" increased from 3707 in 2012 to 6494 in 2016. These trends were consistent across all provider specialties.
Conclusions: Despite a lack of comparative evidence to support its use, the volume of office-based atherectomy procedures in the Medicare population continues to grow dramatically, particularly at the tibial level. These secular trends were similar across provider specialties and have significant cost implications.
Author Disclosures: J. Walker: Nothing to disclose; S. P. Roddy: Nothing to disclose; M. S. Conte: Nothing to disclose.
Financial Analysis of Fenestrated Endovascular Aortic Aneurysm Repair at a High-Volume Medical Center
Warren B. Chow, Denise M. Leverentz, Billi Tatum, Benjamin W. Starnes. University of Washington, Seattle, Wash
Objective: The objective of this study was to examine hospital finances and physician reimbursement associated with fenestrated endovascular aneurysm repair (FEVAR) for complex aortic disease at a high-volume aortic center. Costs and reimbursement for FEVAR were compared with those for open repair, and their trends were analyzed over time.
Methods: Clinical and financial data were retrospectively collected from electronic medical and administrative records. Data for each patient included inpatient and outpatient encounters 3 months before and 12 months after the index operation. AVF, Arteriovenous fistula. 
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